Dongde Wu

414 total citations
17 papers, 274 citations indexed

About

Dongde Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dongde Wu has authored 17 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Dongde Wu's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Dongde Wu is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Dongde Wu collaborates with scholars based in China and United States. Dongde Wu's co-authors include Lequn Bao, Tao Yin, Jing Yu, Chen Hu, Hu Chen, Xin Chen, Chunguang Wang, Qun Wang, Chunjiao Xia and Xiaoqing Yang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Dongde Wu

15 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongde Wu China 10 147 119 94 39 35 17 274
Xiaohong Xu China 9 121 0.8× 72 0.6× 73 0.8× 59 1.5× 32 0.9× 27 268
Yanghui Bi China 12 205 1.4× 87 0.7× 74 0.8× 32 0.8× 43 1.2× 25 352
Feng Du China 9 229 1.6× 164 1.4× 73 0.8× 54 1.4× 20 0.6× 13 364
Shunfang Liu China 9 176 1.2× 97 0.8× 59 0.6× 39 1.0× 22 0.6× 28 285
Sunyoung Chae South Korea 13 246 1.7× 93 0.8× 95 1.0× 30 0.8× 50 1.4× 20 368
Tianliang Xia China 12 241 1.6× 125 1.1× 119 1.3× 81 2.1× 28 0.8× 21 366
Hongji Yang China 14 210 1.4× 172 1.4× 47 0.5× 38 1.0× 30 0.9× 33 358
Vicky M. Coyle United Kingdom 12 152 1.0× 60 0.5× 127 1.4× 41 1.1× 17 0.5× 27 305
Shaohan Wu China 10 190 1.3× 109 0.9× 99 1.1× 42 1.1× 29 0.8× 20 320
Qiliang Lu China 11 222 1.5× 136 1.1× 70 0.7× 35 0.9× 39 1.1× 30 365

Countries citing papers authored by Dongde Wu

Since Specialization
Citations

This map shows the geographic impact of Dongde Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongde Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongde Wu more than expected).

Fields of papers citing papers by Dongde Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongde Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongde Wu. The network helps show where Dongde Wu may publish in the future.

Co-authorship network of co-authors of Dongde Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongde Wu. A scholar is included among the top collaborators of Dongde Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongde Wu. Dongde Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Ping, et al.. (2024). NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma. Scientific Reports. 14(1). 6979–6979. 14 indexed citations
2.
3.
4.
Yuan, Ying, Yanhong Deng, Yongdong Jin, et al.. (2023). Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Preliminary results from a pooled analysis of two phase I studies.. Journal of Clinical Oncology. 41(16_suppl). 3586–3586. 5 indexed citations
5.
Sun, Jiaqi, Jun Ding, Xiyang Wang, et al.. (2022). Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. Journal of Hepatology. 78(3). 627–642. 31 indexed citations
6.
Yu, Jing, Lei Nie, Dongde Wu, et al.. (2021). Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019. Frontiers in Medicine. 7. 597791–597791. 5 indexed citations
7.
Chen, Hu, et al.. (2021). ORC6, Negatively Regulated by miR-1-3p, Promotes Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells. Frontiers in Cell and Developmental Biology. 9. 652292–652292. 16 indexed citations
8.
Wang, Yang, Feng Zhang, Dongde Wu, et al.. (2021). A novel circ_0099999/miR-330-5p/FSCN1 ceRNA crosstalk in pancreatic cancer. Autoimmunity. 54(7). 471–482. 10 indexed citations
9.
Chen, Xin, Chunguang Wang, Chunjiao Xia, et al.. (2020). Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growth. Journal for ImmunoTherapy of Cancer. 8(1). e000785–e000785. 55 indexed citations
10.
Yin, Tao, et al.. (2020). Chemotherapy for breast cancer progresses to liver metastases after surgery and systemic treatment. Translational Cancer Research. 9(2). 993–1000. 2 indexed citations
11.
12.
Hu, Chen, et al.. (2019). 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming. Biomedicine & Pharmacotherapy. 111. 1353–1358. 49 indexed citations
13.
Wang, Qun, et al.. (2019). MEK inhibition by cobimetinib suppresses hepatocellular carcinoma and angiogenesis in vitro and in vivo. Biochemical and Biophysical Research Communications. 523(1). 147–152. 20 indexed citations
14.
Yan, Yi, Dan Qin, Bian Hu, et al.. (2019). Deletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse Model of Cholestasis. Molecular Therapy — Nucleic Acids. 16. 494–504. 25 indexed citations
15.
Fu, Changbo, et al.. (2019). Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma. Medicine. 98(42). e17412–e17412. 15 indexed citations
16.
Wu, Dongde, et al.. (2016). Effect of immune suppression on metastasis in a patient with hepatocellular carcinoma metastasized to the colon and stomach: A case report. Experimental and Therapeutic Medicine. 11(5). 1741–1747. 6 indexed citations
17.
Wu, Dongde, Shaozhong Wei, & Junqiu Yue. (2013). Surgical resection of multiple liver metastasis of functional malignant pheochromocytoma: A case report and literature review. Journal of Cancer Research and Therapeutics. 9(7). 183–183. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohong Xu Breakdown of academic impact, for papers by Yanghui Bi Breakdown of academic impact, for papers by Feng Du Breakdown of academic impact, for papers by Shunfang Liu Breakdown of academic impact, for papers by Sunyoung Chae Breakdown of academic impact, for papers by Tianliang Xia Breakdown of academic impact, for papers by Hongji Yang Breakdown of academic impact, for papers by Vicky M. Coyle Breakdown of academic impact, for papers by Shaohan Wu Breakdown of academic impact, for papers by Qiliang Lu
Rankless by CCL
2026